Sugi Predict

Sugi Predict / Compounds / SCHEMBL3600359

SCHEMBL3600359

SCHEMBL3600359

Cc1cc(O)c2c(c1)CCC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ SELL P14151 1/20 0.42
▸ SELP P16109 1/20 0.42
▸ SELE P16581 1/20 0.42
▸ ACHE P22303 1/20 0.42
▸ BCL2L1 Q07817 1/20 0.42
▸ BAD Q92934 1/20 0.42
▸ NLRP3 Q96P20 4/20 0.37
▸ RAPGEF4 Q8WZA2 1/20 0.37
▸ ACLY P53396 1/20 0.37
▸ UGT2B17 O75795 2/20 0.36
▸ TRPA1 O75762 1/20 0.34
▸ MAPT P10636 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30936614 1.00 MEN1 (0.47) MEN1KMT2ASELLSELPSELE
SCHEMBL3594157 0.96 KMT2A (0.51) MEN1KMT2ASELLSELPSELE
SCHEMBL16347769 0.86 SELL (0.46) MEN1KMT2ASELLSELPSELE
SCHEMBL22361203 0.79 RAPGEF4 (0.44) MEN1KMT2ANLRP3RAPGEF4UGT2B17
SCHEMBL30305680 0.77 BCL2L1 (0.45) MEN1KMT2ABCL2L1BADMAPT
SCHEMBL598081 0.75 MEN1 (0.47) MEN1KMT2ARAPGEF4UGT2B17MAPT
SCHEMBL31261723 0.75 MEN1 (0.47) MEN1KMT2ARAPGEF4UGT2B17MAPT
SCHEMBL8742876 0.74 MEN1 (0.40) MEN1KMT2AACHEBCL2L1BAD
SCHEMBL22618624 0.74 BCL2L1 (0.42) MEN1KMT2AACHEBCL2L1BAD
SCHEMBL8436954 0.74 BCL2L1 (0.42) MEN1KMT2ABCL2L1BADNLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242473-A1 THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. 2023-08-03 — — US disclosed
US-20230242473-A1 THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. 2023-08-03 — — US disclosed
US-20230242473-A1 THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. 2023-08-03 — — US disclosed
US-20230046615-A1 BIOMASS-BASED PESTICIDES AND METHODS OF MAKING THE SAME UNITED STATES DEPARTMENT OF ENERGY 2023-02-16 — — US disclosed
WO-2021257834-A1 THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. (US) 2021-12-23 — — WO disclosed
WO-2021257834-A1 THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. (US) 2021-12-23 — — WO disclosed
US-9388345-B2 Hydrocarbon synthesis methods, apparatus, and systems SARTEC CORPORATION (US) 2016-07-12 — — US disclosed
US-20140046104-A1 HYDROCARBON SYNTHESIS METHODS, APPARATUS, AND SYSTEMS SARTEC CORPORATION 2014-02-13 — — US disclosed
WO-2014008355-A1 HYDROCARBON SYNTHESIS METHODS, APPARATUS, AND SYSTEMS MCNEFF CLAYTON V (US) 2014-01-09 — — WO disclosed
EP-1637527-B1 CANNABINOID RECEPTOR MODULATOR TAKEDA PHARMACEUTICAL (JP) 2013-04-17 — — EP disclosed
US-20100240743-A1 CANNABINOID RECEPTOR MODULATOR TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-09-23 — — US disclosed
US-7507841-B2 Carbamoylamino-substituted 2,3-dihydro-benzofurans, indoles and benzothiophenes, e.g., (+)-N-((3R)-3-(4-isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide; cerebrovascular disorders TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-03-24 — — US disclosed
US-7485669-B2 Anesthetics; anticonvulsants; antiepileptic agents B. BRAUN MELSUNGEN AG (DE) 2009-02-03 — — US disclosed
US-7485669-B2 Anesthetics; anticonvulsants; antiepileptic agents B. BRAUN MELSUNGEN AG (DE) 2009-02-03 — — US disclosed
US-20090023800-A1 Cannabinoid receptor modulator TAKEDA PHARMACEUTICAL COMPANY LIMITED 2009-01-22 — — US disclosed
US-7465815-B2 Cannabinoid receptor modulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-16 — — US disclosed
US-20080021087-A1 Cannabinoid receptor modulator TAKEDA PHARMACEUTICAL COMPANY LIMITED 2008-01-24 — — US disclosed
US-20070099990-A1 Cannabinoid receptor modulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-05-03 — — US disclosed
CN-1816536-A Cannabinoid receptor modulators TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2006-08-09 — — CN disclosed
EP-1637527-A1 CANNABINOID RECEPTOR MODULATOR Takeda Pharmaceutical Company Limited (JP) 2006-03-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230046615-A1 BIOMASS-BASED PESTICIDES AND METHODS OF MAKING THE SAME GHRHR, HCRTR1, CBR3 MEN1 1887/4885KMT2A 535/4885SELL 4047/4885
US-20100240743-A1 CANNABINOID RECEPTOR MODULATOR CNR1, CNR2, GPR18 MEN1 3532/4885KMT2A 1061/4885SELL 3797/4885
US-20080021087-A1 Cannabinoid receptor modulator CNR1, CNR2, GPR18 MEN1 3532/4885KMT2A 1061/4885SELL 3797/4885
US-20090023800-A1 Cannabinoid receptor modulator CNR1, CNR2, GPR18 MEN1 3532/4885KMT2A 1061/4885SELL 3797/4885
US-20230242473-A1 THYROMIMETICS TPO, THOP1, THRB MEN1 629/4885KMT2A 4451/4885SELL 4874/4885
US-20070099990-A1 Cannabinoid receptor modulator CNR1, CNR2, GPR18 MEN1 3532/4885KMT2A 1061/4885SELL 3797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.